Literature DB >> 27810896

An Acrobatic Substrate Metamorphosis Reveals a Requirement for Substrate Conformational Dynamics in Trypsin Proteolysis.

Olumide Kayode1, Ruiying Wang1, Devon F Pendlebury1, Itay Cohen2, Rachel D Henin1, Alexandra Hockla1, Alexei S Soares3, Niv Papo2, Thomas R Caulfield4, Evette S Radisky5.   

Abstract

The molecular basis of enzyme catalytic power and specificity derives from dynamic interactions between enzyme and substrate during catalysis. Although considerable effort has been devoted to understanding how conformational dynamics within enzymes affect catalysis, the role of conformational dynamics within protein substrates has not been addressed. Here, we examine the importance of substrate dynamics in the cleavage of Kunitz-bovine pancreatic trypsin inhibitor protease inhibitors by mesotrypsin, finding that the varied conformational dynamics of structurally similar substrates can profoundly impact the rate of catalysis. A 1.4-Å crystal structure of a mesotrypsin-product complex formed with a rapidly cleaved substrate reveals a dramatic conformational change in the substrate upon proteolysis. By using long all-atom molecular dynamics simulations of acyl-enzyme intermediates with proteolysis rates spanning 3 orders of magnitude, we identify global and local dynamic features of substrates on the nanosecond-microsecond time scale that correlate with enzymatic rates and explain differential susceptibility to proteolysis. By integrating multiple enhanced sampling methods for molecular dynamics, we model a viable conformational pathway between substrate-like and product-like states, linking substrate dynamics on the nanosecond-microsecond time scale with large collective substrate motions on the much slower time scale of catalysis. Our findings implicate substrate flexibility as a critical determinant of catalysis.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  crystal structure; enzyme catalysis; molecular dynamics; molecular modeling; protease inhibitor; protein conformation; protein dynamic; protein structure; proteolysis; serine protease

Mesh:

Substances:

Year:  2016        PMID: 27810896      PMCID: PMC5159493          DOI: 10.1074/jbc.M116.758417

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  74 in total

Review 1.  Steered molecular dynamics and mechanical functions of proteins.

Authors:  B Isralewitz; M Gao; K Schulten
Journal:  Curr Opin Struct Biol       Date:  2001-04       Impact factor: 6.809

2.  Increasing the precision of comparative models with YASARA NOVA--a self-parameterizing force field.

Authors:  Elmar Krieger; Günther Koraimann; Gert Vriend
Journal:  Proteins       Date:  2002-05-15

Review 3.  Serine protease mechanism and specificity.

Authors:  Lizbeth Hedstrom
Journal:  Chem Rev       Date:  2002-12       Impact factor: 60.622

4.  Investigating a back door mechanism of actin phosphate release by steered molecular dynamics.

Authors:  W Wriggers; K Schulten
Journal:  Proteins       Date:  1999-05-01

Review 5.  Canonical protein inhibitors of serine proteases.

Authors:  D Krowarsch; T Cierpicki; F Jelen; J Otlewski
Journal:  Cell Mol Life Sci       Date:  2003-11       Impact factor: 9.261

6.  The role of the protein core in the inhibitory power of the classic serine protease inhibitor, chymotrypsin inhibitor 2.

Authors:  Evette S Radisky; David S King; Gene Kwan; Daniel E Koshland
Journal:  Biochemistry       Date:  2003-06-03       Impact factor: 3.162

7.  A clogged gutter mechanism for protease inhibitors.

Authors:  Evette S Radisky; Daniel E Koshland
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-25       Impact factor: 11.205

Review 8.  Homology modeling.

Authors:  Elmar Krieger; Sander B Nabuurs; Gert Vriend
Journal:  Methods Biochem Anal       Date:  2003

9.  Human mesotrypsin is a unique digestive protease specialized for the degradation of trypsin inhibitors.

Authors:  Richárd Szmola; Zoltán Kukor; Miklos Sahin-Tóth
Journal:  J Biol Chem       Date:  2003-09-24       Impact factor: 5.157

View more
  11 in total

1.  Conformational entropy of a single peptide controlled under force governs protease recognition and catalysis.

Authors:  Marcelo E Guerin; Guillaume Stirnemann; David Giganti
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-19       Impact factor: 11.205

2.  Pre-equilibrium competitive library screening for tuning inhibitor association rate and specificity toward serine proteases.

Authors:  Itay Cohen; Si Naftaly; Efrat Ben-Zeev; Alexandra Hockla; Evette S Radisky; Niv Papo
Journal:  Biochem J       Date:  2018-04-16       Impact factor: 3.857

3.  The bacterial metalloprotease NleD selectively cleaves mitogen-activated protein kinases that have high flexibility in their activation loop.

Authors:  Lihi Gur-Arie; Maayan Eitan-Wexler; Nina Weinberger; Ilan Rosenshine; Oded Livnah
Journal:  J Biol Chem       Date:  2020-05-13       Impact factor: 5.157

4.  Disulfide engineering of human Kunitz-type serine protease inhibitors enhances proteolytic stability and target affinity toward mesotrypsin.

Authors:  Itay Cohen; Matt Coban; Anat Shahar; Banumathi Sankaran; Alexandra Hockla; Shiran Lacham; Thomas R Caulfield; Evette S Radisky; Niv Papo
Journal:  J Biol Chem       Date:  2019-01-30       Impact factor: 5.157

Review 5.  Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies.

Authors:  Yu Yamazaki; Na Zhao; Thomas R Caulfield; Chia-Chen Liu; Guojun Bu
Journal:  Nat Rev Neurol       Date:  2019-07-31       Impact factor: 44.711

6.  Small molecule inhibitors of mesotrypsin from a structure-based docking screen.

Authors:  Olumide Kayode; Zunnan Huang; Alexei S Soares; Thomas R Caulfield; Zigang Dong; Ann M Bode; Evette S Radisky
Journal:  PLoS One       Date:  2017-05-02       Impact factor: 3.240

7.  Attacking COVID-19 Progression Using Multi-Drug Therapy for Synergetic Target Engagement.

Authors:  Mathew A Coban; Juliet Morrison; Sushila Maharjan; David Hyram Hernandez Medina; Wanlu Li; Yu Shrike Zhang; William D Freeman; Evette S Radisky; Karine G Le Roch; Carla M Weisend; Hideki Ebihara; Thomas R Caulfield
Journal:  Biomolecules       Date:  2021-05-23

8.  Accelerated bottom-up drug design platform enables the discovery of novel stearoyl-CoA desaturase 1 inhibitors for cancer therapy.

Authors:  Christina A von Roemeling; Thomas R Caulfield; Laura Marlow; Ilah Bok; Jiang Wen; James L Miller; Robert Hughes; Lori Hazlehurst; Anthony B Pinkerton; Derek C Radisky; Han W Tun; Yon Son Betty Kim; Amy L Lane; John A Copland
Journal:  Oncotarget       Date:  2017-10-06

9.  Protein modeling and clinical description of a novel in-frame GLB1 deletion causing GM1 gangliosidosis type II.

Authors:  John E Richter; Michael T Zimmermann; Patrick R Blackburn; Ahmed N Mohammad; Eric W Klee; Laura M Pollard; Colleen F Macmurdo; Paldeep S Atwal; Thomas R Caulfield
Journal:  Mol Genet Genomic Med       Date:  2018-09-05       Impact factor: 2.183

10.  Molecular Dynamics Simulations Suggest a Non-Doublet Decoding Model of -1 Frameshifting by tRNASer3.

Authors:  Thomas Caulfield; Matt Coban; Alex Tek; Samuel Coulbourn Flores
Journal:  Biomolecules       Date:  2019-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.